Danaher Corporation (DHR)
NYSE
Closed
Aug 21, 2026
Day's Range
213.4652 wk Range
160.93Profile - DHR - Danaher Corporation
Profile
Mic Code
XNYS
Sector
Healthcare
Industry
Diagnostics & Research
Employees
58K
Danaher Corporation is a leading science and technology company that designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. It operates primarily through three key segments: Biotechnology, which provides tools and services for bioprocessing, genomics, and proteomics; Life Sciences, offering advanced instrumentation for research in microscopy, flow cytometry, and mass spectrometry; and Diagnostics, delivering clinical instruments, software, and consumables for laboratory diagnostics, pathology, and healthcare settings. Danaher Corporation's portfolio includes diagnostic equipment, digital imaging systems, optical instruments, microscopes, water quality control systems, and disinfection solutions, serving healthcare providers, research institutions, pharmaceutical companies, and industrial clients. These offerings support critical applications in drug discovery, disease diagnosis, environmental monitoring, and quality assurance across global markets. Founded in 1984 and headquartered in Washington, District of Columbia, Danaher Corporation plays a vital role in advancing scientific innovation and improving health outcomes through its integrated solutions.
Profile Details
Type
Common Stock
Ceo
Mr. Rainer M. Blair
Address
2200 Pennsylvania Avenue N.W.
City
Washington
State
DC
Zip
20037-1701
Country
United States
Phone
202 828 0850
Key Executives - DHR - Danaher Corporation
Key executives
Cross Listings - DHR - Danaher Corporation
Also listed on
The same company trading on other exchanges.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
